Social Determinants of Health and Patient-reported Outcomes Following Autologous Breast Reconstruction, Using Insurance as a Proxy

Abstract

Background Insurance type can serve as a surrogate marker for social determinants of health and can influence many aspects of the breast reconstruction experience. We aimed to examine the impact of insurance coverage on patients reported outcomes with the BREAST-Q (patient reported outcome measure for breast reconstruction patients, in patients receiving) in patients receiving deep inferior epigastric artery perforator (DIEP) flap breast reconstruction.

Methods We retrospectively examined patients who received DIEP flaps at our institution from 2010 to 2019. Patients were divided into categories by insurance: commercial, Medicaid, or Medicare. Demographic factors, surgical factors, and complication data were recorded. Descriptive statistics, Fisher's exact, Kruskal–Wallis rank sum tests, and generalized estimating equations were performed to identify associations between insurance status and five domains of the BREAST-Q Reconstructive module.

Results A total of 1,285 patients were included, of which 1,011 (78.7%) had commercial, 89 (6.9%) had Medicaid, and 185 (14.4%) had Medicare insurances. Total flap loss rates were significantly higher in the Medicare and Medicaid patients as compared to commercial patients; however, commercial patients had a higher rate of wound dehiscence as compared to Medicare patients. With all other factors controlled for, patients with Medicare had lower Physical Well-being of the Chest (PWBC) than patients with commercial insurance (β = − 3.1, 95% confidence interval (CI): −5.0, −1.2, p = 0.002). There were no significant associations between insurance classification and other domains of the BREAST-Q.

Conclusion Patients with government-issued insurance had lower success rates of autologous breast reconstruction. Further, patients with Medicare had lower PWBC than patients with commercial insurance regardless of other factors, while other BREAST-Q metrics did not differ. Further investigation as to the causes of such variation is warranted in larger, more diverse cohorts.

Keywords

social determinants of health - insurance - disparities - breast - autologous - DIEP

^* These authors contributed equally to this manuscript and should be viewed as cofirst authors.

Publikationsverlauf

Eingereicht: 25. Januar 2024

Angenommen: 26. Februar 2024

Accepted Manuscript online:
27. Februar 2024

Artikel online veröffentlicht:
12. April 2024

• References

• 1 Braveman P, Gottlieb L. The social determinants of health: it's time to consider the causes of the causes. Public Health Rep 2014; 129 (Suppl. 02) 19-31
• 2 Gerald MJ, Strand N, Dugue D, Asanbe OA, Jones CM. Beginning to find the missing piece: social determinants of health as a contributor to disparities in plastic surgery. Plast Reconstr Surg 2021; 147 (04) 724e-725e
• 3 Andermann A. CLEAR Collaboration. Taking action on the social determinants of health in clinical practice: a framework for health professionals. CMAJ 2016; 188 (17–18): E474-E483
• 4 U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion; . Healthy People 2030. Available at: https://health.gov/healthypeople Accessed July 7, 2023
• 5 Snyder RA, Chang GJ. Insurance status as a surrogate for social determinants of health in cancer clinical trials. JAMA Netw Open 2020; 3 (04) e203890-e203890
• 6 Marcin JP, Schembri MS, He J, Romano PS. A population-based analysis of socioeconomic status and insurance status and their relationship with pediatric trauma hospitalization and mortality rates. Am J Public Health 2003; 93 (03) 461-466
• 7 Foraker RE, Rose KM, Whitsel EA, Suchindran CM, Wood JL, Rosamond WD. Neighborhood socioeconomic status, Medicaid coverage and medical management of myocardial infarction: atherosclerosis risk in communities (ARIC) community surveillance. BMC Public Health 2010; 10: 632
• 8 Medicaid and CHIP Payment and Access Commission (MACPAC); Racial and Ethnic Disparities in Medicaid: An Annotated Bibliography. Washington DC: Medicaid and CHIP Payment and Access Commission; 2021
• 9 Dewar DM. Do those with more formal education have better health insurance opportunities?. Econ Educ Rev 1998; 17 (03) 267-277
• 10 Centers for Medicare & Medicaid Services. Women's Health and Cancer Rights Act (WHCRA). 2023. Available at: https://www.cms.gov/cciio/programs-and-initiatives/other-insurance-protections/whcra_factsheet Accessed September 18, 2023
• 11 Matros E, Shamsunder M, Disa JJ. Discussion: The effect of the breast cancer provider discussion law on breast reconstruction rates in New York State. Plast Reconstr Surg 2019; 144 (03) 569-570
• 12 Panchal H, Shamsunder MG, Sheinin A. et al. Impact of physician payments on microvascular breast reconstruction: an all-payer claim database analysis. Plast Reconstr Surg 2020; 145 (02) 333-339
• 13 Dinis J, Junn A, Chouairi F. et al. Impact of insurance payer and socioeconomic status on type of autologous breast reconstruction. Surg Oncol 2021; 39: 101661
• 14 Huynh KA, Jayaram M, Wang C. et al. Factors associated with state-specific medicaid expansion and receipt of autologous breast reconstruction among patients undergoing mastectomy. JAMA Netw Open 2021; 4 (08) e2119141
• 15 Meade AE, Cummins SM, Farewell JT. et al. Breaking barriers to breast reconstruction among socioeconomically disadvantaged patients at a large safety-net hospital. Plast Reconstr Surg Glob Open 2022; 10 (07) e4410
• 16 Siotos C, Azizi A, Assam L. et al. Breast reconstruction for medicaid beneficiaries: a systematic review of the current evidence. J Plast Surg Hand Surg 2020; 54 (02) 77-82
• 17 Vieira BL, Lanier ST, Mlodinow AS. et al. A multi-institutional analysis of insurance status as a predictor of morbidity following breast reconstruction. Plast Reconstr Surg Glob Open 2014; 2 (11) e255
• 18 Friedman-Eldar O, Burke J, de Castro Silva I. et al. Stalled at the intersection: insurance status and disparities in post-mastectomy breast reconstruction. Breast Cancer Res Treat 2022; 194 (02) 327-335
• 19 Shippee TP, Kozhimannil KB, Rowan K, Virnig BA. Health insurance coverage and racial disparities in breast reconstruction after mastectomy. Womens Health Issues 2014; 24 (03) e261-e269
• 20 Yang RL, Newman AS, Lin IC. et al. Trends in immediate breast reconstruction across insurance groups after enactment of breast cancer legislation. Cancer 2013; 119 (13) 2462-2468
• 21 Cohen-Levy WB, Lans J, Salimy MS, Melnic CM, Bedair HS. The significance of race/ethnicity and income in predicting preoperative patient-reported outcome measures in primary total joint arthroplasty. J Arthroplasty 2022; 37 (7S): S428-S433
• 22 Cohen WA, Mundy LR, Ballard TN. et al. The BREAST-Q in surgical research: a review of the literature 2009-2015. J Plast Reconstr Aesthet Surg 2016; 69 (02) 149-162
• 23 Liu LQ, Branford OA, Mehigan S. BREAST-Q measurement of the patient perspective in oncoplastic breast surgery: a systematic review. Plast Reconstr Surg Glob Open 2018; 6 (08) e1904
• 24 Nelson JA, Chu JJ, McCarthy CM. et al. BREAST-Q REACT: clinical reference values for the BREAST-Q in post-mastectomy breast reconstruction patients. Ann Surg Oncol 2022; 29 (08) 5280-5293
• 25 Nelson JA, Allen Jr RJ, Polanco T. et al. Long-term patient-reported outcomes following postmastectomy breast reconstruction: an 8-year examination of 3268 patients. Ann Surg 2019; 270 (03) 473-483
• 26 Shamsunder MG, Chu JJ, Polanco TO. et al. the impact of psychiatric diagnoses on patient-reported satisfaction and quality of life in post-mastectomy breast reconstruction. Ann Surg 2023; 277 (06) e1313-e1323
• 27 Le NK, Gabrick KS, Chouairi F, Mets EJ, Avraham T, Alperovich M. Impact of socioeconomic status on psychological functioning in survivorship following breast cancer and reconstruction. Breast J 2020; 26 (09) 1695-1701
• 28 Pirro O, Mestak O, Vindigni V. et al. Comparison of patient-reported outcomes after implant versus autologous tissue breast reconstruction using the BREAST-Q. Plast Reconstr Surg Glob Open 2017; 5 (01) e1217
• 29 U.S. Department of Health and Human Services. What's the difference between Medicare and Medicaid?. Washington, D.C.: : HHS Headquarters. 2022
• 30 Voineskos SH, Klassen AF, Cano SJ, Pusic AL, Gibbons CJ. Giving meaning to differences in BREAST-Q scores: minimal important difference for breast reconstruction patients. Plast Reconstr Surg 2020; 145 (01) 11e-20e
• 31 Armstrong JG, Weigel PA, Cromwell JW, Byrn JC. Postoperative complications and patient satisfaction: does payer status have an impact?. Am J Surg 2016; 211 (06) 1099-1105.e1
• 32 Marquez J, Makadia A, Zlatopolsky A, Hou W, Hajagos J, Khan S. Abstract 184: The effect of insurance payer type on outcomes and readmission rates in patients undergoing breast reconstruction. Plast Reconstr Surg Glob Open 2020; 8 (4S): 124-125
• 33 Hwang K, Son JS, Ryu WK. Smoking and flap survival. Plast Surg (Oakv) 2018; 26 (04) 280-285
• 34 Prantl L, Moellhoff N, Fritschen UV. et al. Impact of smoking status in free deep inferior epigastric artery perforator flap breast reconstruction: a multicenter study. J Reconstr Microsurg 2020; 36 (09) 694-702
• 35 Ooms M, Puladi B, Houschyar KS. et al. Smoking and microvascular free flap perfusion in head and neck reconstruction: radial free forearm flaps and anterolateral thigh flaps. Sci Rep 2022; 12 (01) 13902
• 36 Chouairi F, Mets EJ, Gabrick KS, Dinis J, Avraham T, Alperovich M. Impact of insurance payer on type of breast reconstruction performed. Plast Reconstr Surg 2020; 145 (01) 1e-8e
• 37 Leatherman J, Nicholas C, Cusick T. et al. Intra-operative radiation therapy versus whole breast external beam radiotherapy: a comparison of patient-reported outcomes. Kans J Med 2021; 14: 170-175
• 38 Card D, Dobkin C, Maestas N. Does Medicare save lives?. Q J Econ 2009; 124 (02) 597-636
• 39 Nepon H, Safran T, Reece EM, Murphy AM, Vorstenbosch J, Davison PG. Radiation-induced tissue damage: clinical consequences and current treatment options. Semin Plast Surg 2021; 35 (03) 181-188
• 40 Nelson JA, Cordeiro PG, Polanco T. et al. Association of radiation timing with long-term satisfaction and health-related quality of life in prosthetic breast reconstruction. Plast Reconstr Surg 2022; 150 (01) 32e-41e
• 41 Roth RS, Qi J, Hamill JB. et al. Is chronic postsurgical pain surgery-induced? A study of persistent postoperative pain following breast reconstruction. Breast 2018; 37: 119-125
• 42 Mazuquin B, Sunemi MMO, E Silva MPP, Sarian LOZ, Williamson E, Bruce J. Current physical therapy care of patients undergoing breast reconstruction for breast cancer: a survey of practice in the United Kingdom and Brazil. Braz J Phys Ther 2021; 25 (02) 175-185
• 43 Sharpe JA, Martin BI, Fritz JM. et al. Identifying patients who access musculoskeletal physical therapy: a retrospective cohort analysis. Fam Pract 2021; 38 (03) 203-209
• 44 Higgins MJ, Kale N, Homsy C. et al. Patient perspective on post-breast reconstruction exercise and physical therapy. JPRAS Open 2021; 30: 160-169
• 45 Hanson SE, Lei X, Roubaud MS. et al. Long-term quality of life in patients with breast cancer after breast conservation vs mastectomy and reconstruction. JAMA Surg 2022; 157 (06) e220631
• 46 Oskar S, Nelson JA, Hicks MEV. et al. The impact of race on perioperative and patient-reported outcomes following autologous breast reconstruction. Plast Reconstr Surg 2022; 149 (01) 15-27
• 47 Cross-Call J. Medicaid Expansion Has Helped Narrow Racial Disparities in Health Coverage and Access to Care. Center on Budget and Policy Priorities. 2020
• 48 Long SK, Shen YC. Low-income workers with employer-sponsored insurance: who's at risk when employer coverage is no longer an option?. Med Care Res Rev 2004; 61 (04) 474-494
• 49 New York State Department of Health; Medicaid Buy-In Program for Working People with Disabilities. 2023. . Available at: https://www.health.ny.gov/health_care/medicaid/program/buy_in/ Accessed August 2, 2023